Synergistic activation of human LDL receptor expression by SCAP ligand and cytokine oncostatin M.


OBJECTIVE A recent study identified a new class of compounds designated as the sterol-regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) ligands that putatively bind to SCAP, leading to increased LDL receptor (LDLR) expression. In this study, we examined the effects of SCAP ligand GW707 in comparison with lovastatin and cytokine… (More)


5 Figures and Tables